Susan A Bailey, MD
Vascular Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 52 years
- University of Southern California Keck School of Medicine, 1974
Offices
1 location
Hospitals listed: California Pacific Medical Center - Mission Bernal · UCSF Health Hyde Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bailey’s office at (415) 550-4711 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G29612 · Current
Licensed to practise in California · since 1975 · expires 2027-12-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$165,277
Medicare paid this office $165,277 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $13,463 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $13,398 | $105 |
| Return visit (30+ min) | 26 | $12,926 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $11,206 | $70 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 15 | $9,137 | $223 |
See all 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $13,463 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $13,398 | $105 |
| Return visit (30+ min) | 26 | $12,926 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $11,206 | $70 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 15 | $9,137 | $223 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 12 | $3,374 | $198 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Leg revascularization (restoring blood flow) | 11 | More than 58% of doctors who do this |
| Mastectomy | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of tissue | 268 | More than 93% of doctors who do this |
| Varicose vein removal | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of muscle and/or tissue, 20.0 sq cm or less | 98 | 143 | 147 | 170 | 111 | 41 |
| Strapping, unna boot | 117 | 72 | 99 | 101 | 75 | – |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | – | 116 | – | – | – | – |
| Drainage of fluid filled sacs beneath connective tissue in multiple foot joints | 16 | 19 | – | – | – | – |
| Insertion of 2 central venous tubes in 2 veins for infusion | – | – | 16 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 19% · Women 48% · Also on Medicaid 74% · Health risk score 3.75. Above the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Diabetes 58% · Chronic kidney disease 50% · Coronary heart disease 43% · Heart failure 43% · Depression 40% · Dementia 31% · COPD 28% · Atrial fibrillation 27% · Stroke 21% · Cancer 19%.
The office billed $532,120, Medicare allowed $207,679 and paid $165,277; for 1,004 services of 90 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 1,004 | 73 | 3.75 | $532,120 | $165,277 |
| 2023 | 148 | 1,337 | 75 | 2.99 | $763,859 | $253,709 |
| 2022 | 187 | 1,713 | 74 | 2.75 | $891,873 | $304,828 |
| 2021 | 219 | 1,663 | 73 | 2.62 | $890,398 | $309,255 |
| 2020 | 208 | 1,750 | 74 | 3.01 | $1,041,016 | $332,568 |
| 2019 | 206 | 1,401 | 72 | 2.66 | $808,189 | $266,410 |
| 2018 | 228 | 1,485 | 75 | 2.86 | $766,890 | $253,248 |
| 2017 | 230 | 1,545 | 73 | 3.17 | $924,149 | $275,403 |
| 2016 | 265 | 1,651 | 73 | 2.65 | $976,451 | $294,384 |
| 2015 | 257 | 1,462 | 72 | 2.91 | $883,866 | $273,588 |
| 2014 | 231 | 1,265 | 72 | 2.42 | $762,419 | $229,735 |
| 2013 | 275 | 1,544 | 73 | 2.69 | $1,052,215 | $306,480 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 64 | $36,159 | $121 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 41 | $24,858 | $224 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $14,790 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $13,061 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $12,346 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 34 | $9,170 | $199 |
| Strapping, unna boot | 13 | $7,098 | $95 |
| Ultrasound of leg arteries or artery grafts | 17 | $5,202 | $260 |
| New patient visit (45+ min) | 17 | $2,688 | $158 |
| Ultrasound of leg arteries at rest and after exercise | 17 | $2,653 | $133 |
2022: 10 services
| Return visit (30+ min) | 59 | $38,416 | $117 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 44 | $36,502 | $215 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $22,462 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 107 | $17,969 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $15,872 | $92 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 33 | $10,340 | $203 |
| Strapping, unna boot | 15 | $9,694 | $96 |
| Ultrasound of leg arteries or artery grafts | 18 | $6,114 | $245 |
| Ultrasound of leg arteries at rest and after exercise | 18 | $3,123 | $125 |
| New patient visit (45+ min) | 17 | $2,554 | $150 |
2021: 17 services
| Return visit (30+ min) | 81 | $39,573 | $122 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 48 | $33,662 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $22,408 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $15,427 | $65 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 43 | $12,839 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $12,595 | $94 |
| Strapping, unna boot | 16 | $9,469 | $96 |
| Ultrasound of leg arteries or artery grafts | 17 | $6,561 | $273 |
| New patient visit (45+ min) | 35 | $5,488 | $157 |
| Ultrasound of both sides of head and neck blood flow | 18 | $4,477 | $213 |
| Insertion of 2 central venous tubes in 2 veins for infusion | 13 | $4,034 | $252 |
| Ultrasound of leg arteries at rest and after exercise | 17 | $3,297 | $137 |
| Ultrasound of within the brain blood flow | 18 | $2,957 | $141 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,468 | $123 |
| Short return visit (20+ min) | 11 | $1,501 | $88 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 13 | $267 | $17 |
| Ultrasonic guidance for blood vessel access | 14 | $212 | $12 |
2020: 16 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 47 | $28,192 | $222 |
| Return visit (30+ min) | 69 | $24,990 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $22,075 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $15,799 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $11,955 | $94 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 41 | $11,703 | $198 |
| Ultrasound of leg arteries or artery grafts | 23 | $9,016 | $265 |
| Drainage of fluid filled sacs beneath connective tissue in multiple foot joints | 14 | $7,627 | $401 |
| Strapping, unna boot | 16 | $6,632 | $92 |
| Ultrasound of hemodialysis access | 13 | $5,854 | $139 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 11 | $5,762 | $50 |
| New patient visit (45+ min) | 38 | $5,417 | $143 |
| Ultrasound of leg arteries at rest and after exercise | 23 | $4,538 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,096 | $123 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $1,267 | $79 |
| Short return visit (20+ min) | 14 | $1,217 | $72 |
2019: 15 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 42 | $21,659 | $221 |
| Return visit (30+ min) | 77 | $19,837 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $18,052 | $182 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $12,409 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $11,149 | $66 |
| Strapping, unna boot | 21 | $10,669 | $91 |
| Ultrasound of leg arteries or artery grafts | 25 | $8,313 | $268 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $7,684 | $94 |
| Drainage of fluid filled sacs beneath connective tissue in multiple foot joints | 13 | $7,362 | $460 |
| New patient visit (45+ min) | 33 | $5,070 | $154 |
| Ultrasound of leg arteries at rest and after exercise | 25 | $4,184 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,829 | $123 |
| Ultrasound of both sides of head and neck blood flow | 13 | $2,721 | $209 |
| Ultrasound of within the brain blood flow | 13 | $1,688 | $130 |
| Short return visit (20+ min) | 13 | $1,135 | $71 |
2018: 19 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 42 | $23,426 | $207 |
| Return visit (30+ min) | 95 | $18,897 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $15,890 | $175 |
| Revision of hemodialysis graft with removal of blood clot | 11 | $13,520 | $676 |
| Ultrasound of leg arteries or artery grafts | 37 | $13,377 | $262 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 52 | $13,369 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $11,481 | $63 |
| Strapping, unna boot | 20 | $9,508 | $70 |
| New patient visit (45+ min) | 55 | $8,015 | $146 |
| Ultrasound of leg arteries at rest and after exercise | 37 | $6,783 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $6,201 | $90 |
| Ultrasound of hemodialysis access | 13 | $4,567 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,458 | $117 |
| Ultrasound of both sides of head and neck blood flow | 15 | $3,858 | $203 |
| Insertion of 2 central venous tubes in 2 veins for infusion | 11 | $3,644 | $214 |
| Short return visit (20+ min) | 22 | $2,322 | $66 |
| Ultrasound of within the brain blood flow | 15 | $2,320 | $122 |
| Ultrasonic guidance for blood vessel access | 15 | $321 | $12 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $286 | $16 |
2017: 12 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 32 | $22,371 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $18,030 | $169 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $15,121 | $191 |
| Return visit (30+ min) | 73 | $14,284 | $92 |
| Ultrasound of leg arteries or artery grafts | 37 | $12,899 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $10,294 | $60 |
| Ultrasound of leg arteries at rest and after exercise | 37 | $6,705 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,690 | $87 |
| Ultrasound of hemodialysis access | 22 | $6,669 | $136 |
| New patient visit (45+ min) | 46 | $6,512 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,517 | $113 |
| Short return visit (20+ min) | 17 | $2,462 | $60 |
2016: 22 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $17,778 | $178 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 54 | $13,952 | $194 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 16 | $12,623 | $188 |
| Return visit (30+ min) | 68 | $11,901 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $10,905 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $9,038 | $91 |
| Ultrasound of leg arteries or artery grafts | 27 | $8,250 | $201 |
| Revision of hemodialysis graft with removal of blood clot | 11 | $8,139 | $678 |
| Strapping, unna boot | 14 | $7,958 | $70 |
| New patient visit (45+ min) | 50 | $7,366 | $147 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 54 | $7,091 | $98 |
| Ultrasound of leg arteries at rest and after exercise | 27 | $5,836 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $5,631 | $120 |
| Insertion of 2 central venous tubes in 2 veins for infusion | 14 | $3,940 | $246 |
| Ultrasound of both sides of head and neck blood flow | 14 | $3,257 | $192 |
| Short return visit (20+ min) | 27 | $2,936 | $62 |
| Ultrasound of hemodialysis access | 11 | $2,414 | $121 |
| Long return visit (40+ min) | 17 | $2,167 | $127 |
| Ultrasound of within the brain blood flow | 14 | $2,070 | $122 |
| Insertion of needle and/or catheter for dialysis | 13 | $1,543 | $86 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $299 | $17 |
| Ultrasonic guidance for blood vessel access | 15 | $239 | $13 |
2015: 18 services
| Revision of hemodialysis graft with removal of blood clot | 15 | $15,094 | $686 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $13,341 | $180 |
| Strapping, unna boot | 19 | $12,130 | $63 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 50 | $11,928 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $10,899 | $64 |
| Return visit (30+ min) | 78 | $9,744 | $97 |
| Ultrasound of leg arteries or artery grafts | 26 | $8,924 | $241 |
| New patient visit (45+ min) | 58 | $8,578 | $148 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 50 | $5,887 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $5,713 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,564 | $93 |
| Ultrasound of leg arteries at rest and after exercise | 26 | $5,280 | $143 |
| Short return visit (20+ min) | 26 | $2,822 | $67 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 11 | $2,393 | $218 |
| New patient visit (60+ min) | 13 | $2,389 | $184 |
| Insertion of needle and/or catheter for dialysis | 15 | $1,907 | $83 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 13 | $284 | $17 |
| Ultrasonic guidance for blood vessel access | 13 | $219 | $13 |
2014: 13 services
| Strapping, unna boot | 15 | $12,164 | $63 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 40 | $9,459 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,395 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $8,490 | $64 |
| Return visit (30+ min) | 55 | $7,867 | $94 |
| New patient visit (45+ min) | 51 | $7,685 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,746 | $122 |
| Short return visit (20+ min) | 46 | $5,249 | $66 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 40 | $4,968 | $99 |
| Ultrasound of leg arteries or artery grafts | 19 | $4,807 | $240 |
| Ultrasound of leg arteries at rest and after exercise | 19 | $2,870 | $143 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 11 | $2,795 | $233 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,692 | $93 |
2013: 16 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,257 | $176 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 46 | $10,793 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $9,627 | $63 |
| Return visit (30+ min) | 64 | $9,501 | $100 |
| Ultrasound of leg arteries or artery grafts | 33 | $8,777 | $199 |
| New patient visit (45+ min) | 55 | $8,379 | $152 |
| Strapping, unna boot | 20 | $8,008 | $47 |
| Short return visit (20+ min) | 57 | $7,606 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,543 | $118 |
| Ultrasound of leg arteries at rest and after exercise | 33 | $6,554 | $149 |
| Ultrasound study of veins of both arms or legs including assessment of functional maneuvers | 46 | $5,750 | $103 |
| Insertion of needle and/or catheter for dialysis | 12 | $2,833 | $101 |
| Ultrasound of both sides of head and neck blood flow | 11 | $2,103 | $191 |
| New patient visit (30+ min) | 20 | $2,021 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,706 | $90 |
| Ultrasound of within the brain blood flow | 11 | $1,061 | $96 |
Medicaid work
$12,266 in 2024
Medicaid paid $12,266 for 164 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 94 | $7,660 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 57 | $3,330 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 13 | $1,277 |
| 2024 | 164 | 3 | 17 | $12,266 |
| 2023 | 176 | 5 | 13 | $35,430 |
| 2022 | 46 | 3 | 12 | $10,339 |
| 2021 | 178 | 4 | 17 | $14,044 |
| 2020 | 56 | 2 | 15 | $5,233 |
| 2019 | 121 | 3 | 13 | $3,972 |
| 2018 | 56 | 2 | 19 | $1,635 |
See the largest Medicaid services in earlier years
2023
| Incision and drainage of deep abscess of ankle | 43 | $21,972 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 39 | $5,667 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 53 | $3,975 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 20 | $2,974 |
| Return visit (30+ min) | 21 | $842 |
2022
| Incision and drainage of deep abscess of ankle | 19 | $7,046 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 15 | $1,835 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $1,458 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 104 | $7,058 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 33 | $4,433 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 21 | $1,296 |
| Return visit (30+ min) | 20 | $1,257 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 41 | $3,029 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 15 | $2,204 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 90 | $2,885 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $854 |
| Return visit (30+ min) | 19 | $233 |
2018
| Return visit (30+ min) | 44 | $893 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $742 |
Drugs they prescribed that Part D paid
$2,206
Pharmacies billed $2,206 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 32% of their Part D prescriptions (17 of 54) in 2024. Above the middle of the specialty; the typical vascular surgery clinician is at 11%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
48 generic and fewer than 11 brand-name prescriptions · $2,206 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 54 | 21 | 32% (17) | None | $2,206 |
| 2023 | 92 | 38 | None | 13% | $6,178 |
| 2022 | 96 | 44 | 20% (19) | None | $1,719 |
| 2021 | 137 | 53 | 17% (23) | 11% | $5,723 |
| 2020 | 130 | 50 | 36% (47) | 14% | $7,441 |
| 2019 | 161 | 57 | 23% (37) | 22% | $9,051 |
| 2018 | 169 | 55 | 32% (54) | 13% | $8,345 |
| 2017 | 131 | 62 | 25% (33) | None | $5,137 |
| 2016 | 167 | 71 | 25% (41) | 7% | $6,099 |
| 2015 | 220 | 87 | 32% (71) | 7% | $7,625 |
| 2014 | 208 | 86 | 24% (49) | None | $6,025 |
| 2013 | 255 | 96 | 32% (81) | None | $6,190 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Atorvastatin | 11 | $156 | $14 |
2022: 2 drugs
| Atorvastatin | 14 | $224 | $16 |
| Hydrocodone-Acetaminophen | 16 | $157 | $10 |
2021: 2 drugs
| Hydrocodone-Acetaminophen | 11 | $83 | $8 |
| Gabapentin | 11 | $77 | $7 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 29 | $332 | $11 |
2019: 4 drugs
| Santyl | 12 | $2,867 | $239 |
| Hydrocodone-Acetaminophen | 31 | $234 | $8 |
| Clopidogrel | 14 | $190 | $14 |
| Furosemide | 19 | $71 | $4 |
2018: 3 drugs
| Hydrocodone-Acetaminophen | 40 | $330 | $8 |
| Sulfamethoxazole-Trimethoprim | 19 | $112 | $6 |
| Furosemide | 13 | $39 | $3 |
2017: 2 drugs
| Clopidogrel | 14 | $239 | $17 |
| Hydrocodone-Acetaminophen | 23 | $105 | $5 |
2016: 3 drugs
| Hydrocodone-Acetaminophen | 38 | $356 | $9 |
| Ibuprofen | 32 | $268 | $8 |
| Clopidogrel | 14 | $186 | $13 |
2015: 4 drugs
| Hydrocodone-Acetaminophen | 59 | $643 | $11 |
| Clopidogrel | 27 | $371 | $14 |
| Atorvastatin | 11 | $250 | $23 |
| Ibuprofen | 40 | $230 | $6 |
2014: 5 drugs
| Hydrocodone-Acetaminophen | 34 | $410 | $12 |
| Clopidogrel | 16 | $262 | $16 |
| Ibuprofen | 18 | $93 | $5 |
| Hydromorphone | 11 | $80 | $7 |
| Furosemide | 16 | $53 | $3 |
2013: 6 drugs
| Hydrocodone-Acetaminophen | 66 | $942 | $14 |
| Clopidogrel | 18 | $309 | $17 |
| Hydromorphone | 11 | $213 | $19 |
| Gabapentin | 18 | $121 | $7 |
| Amlodipine Besylate | 11 | $64 | $6 |
| Furosemide | 15 | $47 | $3 |
Money from drug and device companies
$220 in 2025
| 2025 | 7 | 9 | None | $220 |
| 2024 | 4 | 5 | None | $106 |
| 2023 | 8 | 13 | None | $288 |
| 2022 | 7 | 16 | None | $356 |
| 2021 | 10 | 22 | None | $438 |
| 2020 | 7 | 9 | None | $176 |
| 2019 | 12 | 32 | None | $1,247 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $52 | 2 payments
|
| GlaxoSmithKline | Shingrix | $47 | 2 payments
|
| Astellas Pharma US | Veozah | $32 | 1 payment
|
| Amgen | Evenity | $24 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $22 | 1 payment
|
| Lilly USA | Jardiance | $22 | 1 payment
|
See all 9 published payments
| Astellas Pharma US | Meals · 2025-10-06 | Veozah | $32 |
| Abbvie | Meals · 2025-08-27 | Ubrelvy | $20 |
| Lilly USA | Meals · 2025-08-01 | Jardiance | $22 |
| Amgen | Meals · 2025-05-14 | Evenity | $24 |
| Kowa Pharmaceuticals America | Meals · 2025-05-12 | Zoryve | $21 |
| GlaxoSmithKline | Meals · 2025-05-07 | Shingrix | $20 |
| Abbvie | Meals · 2025-05-06 | Ubrelvy | $32 |
| Merck Sharp & Dohme | Meals · 2025-03-12 | Gardasil 9 | $22 |
| GlaxoSmithKline | Meals · 2025-02-05 | Shingrix | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $106
| Novo Nordisk | Ozempic | $46 | 2 payments
|
| Amgen | Otezla | $24 | 1 payment
|
| Kowa Pharmaceuticals America | Zoryve | $20 | 1 payment
|
| RGH Enterprises | None | $16 | 1 payment
|
2023: $288
| Amgen | Evenity | $75 | 3 payments
|
| Novo Nordisk | Wegovy | $71 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $41 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| ViiV Healthcare | Apretude | $22 | 1 payment
|
| Lilly USA | Emgality | $19 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $19 | 1 payment
|
| Medtronic | Minimed 780g | $18 | 1 payment
|
2022: $356
| Amgen | Evenity | $94 | 3 payments
|
| Janssen Pharmaceuticals | Ponvory | $87 | 4 payments
|
| Lilly USA | Jardiance | $43 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $43 | 2 payments
|
| Novo Nordisk | None | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $17 | 1 payment
|
2021: $438
| Amgen | Evenity | $80 | 3 payments
|
| Merck Sharp & Dohme | Belsomra | $79 | 4 payments
|
| Novo Nordisk | Wegovy | $68 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $68 | 3 payments
|
| Eisai | Dayvigo | $38 | 2 payments
|
| Lilly USA | Emgality | $36 | 2 payments
|
| AbbVie | Vraylar | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $16 | 1 payment
|
| Seqirus USA | Fluad Quadrivalent | $15 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $13 | 1 payment
|
2020: $176
| Novo Nordisk | Saxenda | $37 | 2 payments
|
| Lilly USA | Glyxambi | $27 | 2 payments
|
| Pfizer | Chantix | $25 | 1 payment
|
| Amgen | Evenity | $23 | 1 payment
|
| Radius Health | Tymlos | $22 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
2019: $1,247
| Medtronic Vascular | Hawkone | $909 | 13 payments
|
| Pfizer | Eliquis | $66 | 3 payments
|
| Smith+Nephew | Santyl | $52 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $41 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $40 | 3 payments
|
| Novo Nordisk | Saxenda | $30 | 2 payments
|
| Boston Scientific | Eluvia | $23 | 1 payment
|
| Merck Sharp & Dohme | Nexplanon | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Lilly USA | Glyxambi | $18 | 1 payment
|
| Acell | None | $16 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $15 | 1 payment
|
Professional record
- NPI
- 1487742425
- Licence
- CA G29612California G29612: Current · expires 2027-12-31
- Trained
- University of Southern California Keck School of Medicine, 1974 · 52 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G296120
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 1580 Valencia St Ste 201, San Francisco, CA, 94110
- NPI first listed
- 2006-10-11
- NPI last updated
- 2018-10-03
This is when the NPI record was last certified, not a medical board exam.